BioAI-global
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioAI-global - overview
Established
2021
Location
Tianjin, -, China
Primary Industry
Pharmaceuticals
About
Founded in 2021 in and based in Tianjin, China, BioAI-global operates as a drug development company that focuses on artificial intelligence-assisted drug discovery. The company has applied for 3 patents, with 6 software copyrights. Jianping Lin, the company's founder and chief scientist, graduated from Duke University and is also a professor at the School of Pharmacy of Nankai University. He was a postdoctoral researcher at the Beckman Research Institute of City of Hope Medical Center in the United States.
In December 2024, BioAI-global closed an angel funding. BioAI-global's main business is the research and development of artificial intelligence-assisted drug discovery (AIDD) technology. It has a number of technology platforms, including small molecule drug discovery platform, target prediction platform, traditional Chinese medicine computing platform, and other AI-driven new drug development and service platforms. The products can be used to treat tumors, respiratory diseases, and neurodegenerative diseases.
The target customers of the company are pharmaceutical companies, academic institutions, hospitals, and research organizations. The company generates revenue by providing artificial intelligence-assisted drug discovery (AIDD) technologied and platforms.
Current Investors
Renxi Fund
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.bioai-global.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.